Cellective Therapeutics
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Cellective Therapeutics Information
Cellective Therapeutics was acquired by
MedImmune.
The acquisition happend on 2005-09-15.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Gaithersburg
State: Maryland
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$28M
Raised Total:$28M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company&s;s technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body&s;s normal response to infections.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2004 | Series A | 8 | $27.5M |
Alta Partners BA Venture Partners Forward Ventures Genentech Intersouth Partners Latterell Venture Partners MedImmune Ventures Sofinnova Investments Alta Partners BA Venture Partners Forward Ventures Genentech Intersouth Partners Latterell Venture Partners MedImmune Ventures Sofinnova Investments |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
